Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ketoprofen lysinate
Cat. No.:
OB0425LY-259
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Ketoprofen lysinate is a nonsteroidal anti-inflammatory drug (NSAID), the lysine salt form of ketoprofen, with anti-inflammatory, analgesic and antipyretic properties.
Synonyms:
57469-78-0; Ketoprofen lysine; Ketoprofen lysine salt; L-Lysine, mono(3-benzoyl-alpha-methylbenzeneacetate); RP-19583 (lysinate)
CAS No.:
57469-78-0
Compound CID:
9843941
Formula:
C22H28N2O5
Formula Weight:
400.47
Specification
Target:
COX
Pathway:
Immunology/Inflammation
Storage:
Storage at -20°C.
Applications:
Ketoprofen lysinate can be used to inhibit COX-1 and COX-2 in metabolic pathways.
